chr7-150974854-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The ENST00000262186.10(KCNH2):c.164C>T(p.Ser55Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,458,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S55W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000262186.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.164C>T | p.Ser55Leu | missense_variant | 2/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.164C>T | p.Ser55Leu | missense_variant | 2/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 | |
KCNH2 | ENST00000532957.5 | n.387C>T | non_coding_transcript_exon_variant | 2/9 | 2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458400Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 725420
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 11, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate a damaging effect, consistent with near complete loss-of-function (PMID: 25417810, 29330128); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15840476, 18508782, 29330128, 37324772, 25417810, 22396785, 35688148, 37187232, 32475984, 36861347) - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 09, 2021 | The p.S55L variant (also known as c.164C>T), located in coding exon 2 of the KCNH2 gene, results from a C to T substitution at nucleotide position 164. The serine at codon 55 is replaced by leucine, an amino acid with dissimilar properties, and is located in the PAS domain. This variant co-occurred with a KCNQ1 variant in a proband with long QT syndrome (LQTS). Two of the proband's children who carried p.S55L alone were also affected with LQTS (Kroncke BM et al. Heart Rhythm, 2018 06;15:890-894). This variant was also identified in individuals from another family with LQTS and in a LQTS genetic testing cohort (Behr ER et al. Eur Heart J, 2008 Jul;29:1670-80l Tester DJ et al. Heart Rhythm, 2005 May;2:507-17). This variant has been reported to result in deficient protein trafficking and abnormal ion channel function in in vitro assays (Anderson CL et al. Nat Commun, 2014 Nov;5:5535; Kroncke BM et al. Heart Rhythm, 2018 06;15:890-894). Based on internal structural analysis, this variant is predicted to be disruptive to the PAS domain (Haitin Y et al. Nature. 2013 Sep;501(7467):444-8; Wang W et al. Cell. 2017 04;169(3):422-430.e10). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 25, 2022 | This missense change has been observed in individual(s) with KCNH2-related conditions (PMID: 18508782, 29330128). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 55 of the KCNH2 protein (p.Ser55Leu). ClinVar contains an entry for this variant (Variation ID: 67224). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 25417810, 29330128). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:18508782). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at